SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-161749
Filing Date
2015-04-30
Accepted
2015-04-30 16:01:43
Documents
8
Period of Report
2015-06-19
Effectiveness Date
2015-04-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d914222ddef14a.htm DEF 14A 840750
2 GRAPHIC g914222g12v98.jpg GRAPHIC 6534
3 GRAPHIC g914222pc_pg01e.jpg GRAPHIC 1358
4 GRAPHIC g914222pc_pg01f.jpg GRAPHIC 576
5 GRAPHIC g914222pc_pg01g.jpg GRAPHIC 778
6 GRAPHIC g914222pc_pg01new.jpg GRAPHIC 121719
7 GRAPHIC g914222pc_pg02c.jpg GRAPHIC 1006
8 GRAPHIC g914222pc_pg02new.jpg GRAPHIC 3949
  Complete submission text file 0001193125-15-161749.txt   1030205
Mailing Address 1901 CAMPUS PLACE LOUISVILLE KY 40299
Business Address 1901 CAMPUS PLACE LOUISVILLE KY 40299 502.627.7000
PharMerica CORP (Filer) CIK: 0001388195 (see all company filings)

IRS No.: 870792558 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33380 | Film No.: 15818353
SIC: 5912 Retail-Drug Stores and Proprietary Stores